Patten Group, Inc. Biogen Inc. Transaction History

Patten Group, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 14, 2019	SELL	$216.71 - $338.96 $104,454 - $163,378	-482 Closed	0 $0
Q4 2018 Feb 12, 2019	BUY	$278.5 - $352.75 $2,785 - $3,527	10 Added 2.12%	482 $145,000
Q4 2017 Feb 02, 2018	BUY	$307.64 - $344.58 $3,076 - $3,445	10 Added 2.16%	472 $150,000
Q3 2017 Dec 13, 2017	SELL	$281.15 - $329.69 $5.6 Million - $6.56 Million	-19,906 Reduced 97.73%	462 $145,000
Q3 2017 Nov 14, 2017	BUY	$281.15 - $329.69 $5.6 Million - $6.56 Million	19,906 Added 4308.66%	20,368 $145,000
Q2 2017 Aug 14, 2017	BUY	N/A	462	462 $133,000

995

131M

1.12M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Patten Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Patten Group, Inc. with notifications on news.